Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Receivables (2019 - 2025)

Historic Receivables for IM Cannabis (IMCC) over the last 6 years, with Q4 2024 value amounting to $10.1 million.

  • IM Cannabis' Receivables rose 5969.32% to $10.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $10.1 million, marking a year-over-year increase of 5969.32%. This contributed to the annual value of $10.3 million for FY2024, which is 6148.13% up from last year.
  • IM Cannabis' Receivables amounted to $10.1 million in Q4 2024, which was up 5969.32% from $6.3 million recorded in Q4 2023.
  • Over the past 5 years, IM Cannabis' Receivables peaked at $20.4 million during Q4 2021, and registered a low of $4.3 million during Q4 2020.
  • In the last 5 years, IM Cannabis' Receivables had a median value of $6.5 million in 2022 and averaged $9.5 million.
  • In the last 5 years, IM Cannabis' Receivables soared by 37369.13% in 2021 and then crashed by 6789.27% in 2022.
  • Over the past 5 years, IM Cannabis' Receivables (Quarter) stood at $4.3 million in 2020, then soared by 373.69% to $20.4 million in 2021, then crashed by 67.89% to $6.5 million in 2022, then fell by 3.52% to $6.3 million in 2023, then skyrocketed by 59.69% to $10.1 million in 2024.
  • Its Receivables stands at $10.1 million for Q4 2024, versus $6.3 million for Q4 2023 and $6.5 million for Q4 2022.